NOVAVAX INC Uncategorized Contracts & Agreements

37 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Offer Letter to
NOVAVAX INC
Biotechnology
2024
Offer Letter to Elaine OHara dated
NOVAVAX INC
Biotechnology
2024
Offer letter to
NOVAVAX INC
Biotechnology
2024
Description of the Company's Securities
NOVAVAX INC
Biotechnology
2024
Description of the Company's Securities
NOVAVAX INC
Biotechnology
2023
Novavax, Inc. 2023 Inducement Plan
NOVAVAX INC
Biotechnology
MD
2023
Amendment of Solicitation/Modification of Contract No. 4, dated as of July 29, 2022, between the Company. and the U.S. Department of Defense Joint Program Executive Office for...
NOVAVAX INC
Biotechnology
2022
Description of
NOVAVAX INC
Biotechnology
2022
Offer letter to James P. Kelly dated July
NOVAVAX INC
Biotechnology
2021
Offer letter to Gregory F. Covino dated October 30, 2020
NOVAVAX INC
Biotechnology
2021
Description of Registrants Securities
NOVAVAX INC
Biotechnology
2021
Letter Contract, entered into on June 8, 2020, by and between the Company and the U.S. Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological...
NOVAVAX INC
Biotechnology
2020
Description of Registrants Securities
NOVAVAX INC
Biotechnology
2020
NOVAVAX, INC. AMENDED AND RESTATED CHANGE IN CONTROLSEVERANCE BENEFIT PLAN Adopted by the Board of Directors August10, 2005 Amended by the Board of Directors July26, 2006 Amended...
NOVAVAX INC
Biotechnology
2017
JPMorgan Chase Bank, National Association Organised under the laws of the United Statesas a National Banking Association. Main Office 1111 Polaris Parkway, Columbus,Ohio 43240...
NOVAVAX INC
Biotechnology
2016
W I T N E S S E T H:
NOVAVAX INC
Biotechnology
2016
JPMorgan Chase Bank, National Association Organised under the laws of the United States as a National Banking Association. Main Office 1111 Polaris Parkway, Columbus, Ohio 43240...
NOVAVAX INC
Biotechnology
2016
[**] = Portions of this exhibit have been omittedpursuant to a confidential treatment request. An unredacted version of this exhibit has beenfiled separately with the Commission.
NOVAVAX INC
Biotechnology
NY
2015
Exhibit 10.1
NOVAVAX INC
Biotechnology
MD
2011
Guidelines On Significant Corporate Governance Issues Effective January 1, 2011
NOVAVAX INC
Biotechnology
2011
THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES...
NOVAVAX INC
Biotechnology
NY
2011
THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES...
NOVAVAX INC
Biotechnology
2011
6,800,000 Shares and 1,020,000 Over-Allotment Shares
NOVAVAX INC
Biotechnology
NY
2009
THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES...
NOVAVAX INC
Biotechnology
2009
THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES...
NOVAVAX INC
Biotechnology
MD
2009
NOVAVAX, INC.
NOVAVAX INC
Biotechnology
2009
THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTEDMATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES...
NOVAVAX INC
Biotechnology
2008
THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES...
NOVAVAX INC
Biotechnology
2008
THISEXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF ACONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH[* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND...
NOVAVAX INC
Biotechnology
MA
2007
NOVAVAX, INC.
NOVAVAX INC
Biotechnology
2006
[Letterhead of Pharmelle, LLC]
NOVAVAX INC
Biotechnology
2006
Part I. Financial Information
NOVAVAX INC
Biotechnology
MD
2003
[Novavax Letterhead]
NOVAVAX INC
Biotechnology
DE
2002
[Novavax Letterhead]
NOVAVAX INC
Biotechnology
DE
2002
Agreement of Lease-W.M.Rickman Construction Co
NOVAVAX INC
Biotechnology
2002
SECOND AMENDMENT TO THE COPROMOTION AGREEMENT
NOVAVAX INC
Biotechnology
2001
FIRST AMENDMENT TO THE COPROMOTION AGREEMENT
NOVAVAX INC
Biotechnology
2001